Skip to content

13F-HR filed by Yu Fan

Yu Fan filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 3 holding rows worth $13,487,000.

Accession
0000950123-21-002356
Filed
2021-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A combination report, 3 entries on the cover page, a total value of $13,487,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $13,487,000 with VALUE read as thousands by filing date, 13F file number 028-20833. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerABG Innovation Capital Partners III GP Limited
  • reports for this filerAlly Bridge Group (NY) LLC

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ATEA PHARMACEUTICALS INC04683R106COMMON STOCK300,000$12,534,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM112,044$882,000thousands by filing date
DIFFUSION PHARMACEUTICALS IN253748305COM PAR89,848$71,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-21-002356this filing2021-02-16acceptance time not in the bulk data set
13F-HR/A 0000950123-21-006743 added2021-05-17acceptance time not in the bulk data set